Halozyme Therapeutics shares owned by WCM Investment Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by WCM Investment Management
from 13F filings
Historical chart of WCM Investment Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by WCM Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Halozyme Therapeutics by WCM Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $18M | 284k | 63.84 |
| 2024-12-31 | $14M | 285k | 47.99 |
| 2024-09-30 | $17M | 300k | 56.97 |
| 2024-06-30 | $16M | 311k | 51.63 |
| 2024-03-31 | $13M | 306k | 40.68 |
| 2023-12-31 | $12M | 317k | 37.15 |
| 2023-09-30 | $11M | 292k | 38.20 |
| 2023-06-30 | $8.6M | 236k | 36.55 |
| 2023-03-31 | $8.4M | 220k | 38.19 |
| 2021-09-30 | $5.5M | 136k | 40.68 |
| 2021-06-30 | $6.1M | 135k | 45.41 |
| 2021-03-31 | $5.4M | 130k | 41.69 |
| 2020-12-31 | $5.7M | 133k | 42.71 |
| 2020-09-30 | $3.5M | 132k | 26.28 |
| 2020-06-30 | $5.5M | 204k | 26.81 |
| 2020-03-31 | $3.5M | 194k | 17.99 |
| 2019-12-31 | $2.4M | 137k | 17.73 |
| 2019-09-30 | $489k | 32k | 15.52 |
| 2019-06-30 | $541k | 32k | 17.17 |
| 2019-03-31 | $515k | 32k | 16.10 |